# US 2024/0189028 A1 · Systems and methods for increasing metabolic rates

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0189028 A1
- Document ID: US20240189028A1
- Status: Published application
- Kind: A1
- Application number: 18/554,536
- Filed: 2022-04-11
- Published: 2024-06-13
- Earliest claimed: 2021-04-09
- Assignees: The General Hospital Corporation
- Applicants: The General Hospital Corporation
- Inventors: Dieter Manstein; Michael Wang-Evers; Nunciada Salma
- Web page: https://patentgrep.com/patent/US20240189028A1

## CPC

- A61B 18/203: {applying laser energy to the outside of the body}
- A61N 1/0502: {Skin piercing electrodes}
- A61B 18/1206: {Generators therefor}
- A61B 18/1477: {Needle-like probes}
- A61B 34/30: Surgical robots
- A61B 90/50: Supports for surgical instruments, e.g. articulated arms
- A61N 1/36017: {with leads or electrodes penetrating the skin}
- A61N 5/0616: {Skin treatment other than tanning}
- A61N 7/02: Localised ultrasound hyperthermia
- A61B 18/201: {with beam delivery through a hollow tube, e.g. forming an articulated arm (through a flexible conduit A61B18/22); Hand-pieces therefor}
- A61B 18/22: the beam being directed along or through a flexible conduit, e.g. an optical fibre; {Couplings or} hand-pieces therefor
- A61B 2018/00017: {with gas}
- A61B 2018/00023: {closed, i.e. without wound contact by the fluid}
- A61B 2018/00029: {open}
- A61B 2018/00452: {Skin}
- A61B 2018/00464: {Subcutaneous fat, e.g. liposuction, lipolysis}
- A61B 2018/0047: {Upper parts of the skin, e.g. skin peeling or treatment of wrinkles}
- A61B 2018/00577: {Ablation}
- A61B 2018/00589: {Coagulation}
- A61B 2018/00625: {Vaporization}
- A61B 2018/00642: {with feedback, i.e. closed loop control}
- A61B 2018/00648: {using more than one sensed parameter}
- A61B 2018/00702: {Power or energy}
- A61B 2018/00732: {Frequency}
- A61B 2018/143: {multiple needles}
- A61B 2018/2211: {Plurality of fibres}
- A61B 2090/0436: {Shielding}
- A61N 5/0625: {Warming the body, e.g. hyperthermia treatment}
- A61N 5/067: using laser light
- A61N 7/00: Ultrasound therapy (lithotripsy A61B17/22, A61B17/225; massage using supersonic vibration A61H23/00 {; using ultrasound for introducing media into the body A61M37/0092})
- A61N 2005/063: {comprising light transmitting means, e.g. optical fibres}
- A61N 2005/0643: {Applicators, probes irradiating specific body areas in close proximity}
- A61N 2005/0644: {Handheld applicators}
- A61N 2007/0008: {Destruction of fat cells}
- A61N 2007/0034: {Skin treatment}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

A treatment system can include an energy source configured to thermally damage skin tissue of a subject, a user input device configured to receive a user input, and a computing device that can be configured to receive, from the user input device, the user input indicative of one or more operational parameters of the energy source based on the user input, control the energy source according to the one or more operational parameters to cause the energy source to thermally damage the skin tissue by creating a plurality of treatment regions within a target region of the skin tissue to increase a basal metabolic rate of the subject, wherein the target region includes a non-treatment portion that is interspersed among the treatment regions.

## Claims

### Claim 1

A treatment system comprising:
an energy source configured to thermally damage skin tissue of a subject;
a user input device configured to receive a user input;
a computing device configured to:
receive, from the user input device, the user input indicative of one or more operational parameters of the energy source;
based on the user input, control the energy source according to the one or more operational parameters to cause the energy source to thermally damage the skin tissue by creating a plurality of treatment regions within a target region of the skin tissue to increase a basal metabolic rate of the subject, wherein the target region includes a non-treatment portion that is interspersed among the treatment regions.

### Claim 2 (depends on 1)

The treatment system of claim 1, wherein the computing device is further configured to control the energy source according to the one or more operational parameters to randomly distribute the treatment regions among the target region of the skin tissue.

### Claim 3 (depends on 1)

The treatment system of claim 1, wherein the creation of the treatment regions are configured to decrease an amount of fat of the subject.

### Claim 4 (depends on 1)

The treatment system of claim 1, wherein the plurality of treatment regions form an array of treatment regions within the target region;
wherein the array includes multiple columns and multiple rows; and
wherein the treatment regions are in the multiple columns and the multiple rows of the array.

### Claim 5 (depends on 4)

The treatment system of claim 4, wherein the energy source is the transducer that is a light source; and
wherein the computing device is further configured to cause the light source to emit light towards the target region of the skin tissue to form the plurality of treatment regions of the skin tissue.

### Claim 6 (depends on 5)

The treatment system of claim 5, wherein the computing device is further configured to cause the light source to emit a plurality of beams of light towards the target region of the skin tissue; and
wherein each beam of the plurality of beams creates a respective treatment region of the plurality of treatment regions of the skin tissue.

### Claim 7 (depends on 5)

The treatment system of claim 5, wherein the light source is configured to generate a fractional illumination pattern that is directed at the target region to form the plurality of treatment regions and the non-treatment region.

### Claim 8 (depends on 5)

The treatment system of claim 5, wherein each of the plurality of treatment regions of the skin is a non-ablative treatment region.

### Claim 9 (depends on 8)

The treatment system of claim 8, wherein the controller is further configured to control the light source to deliver less than or equal to 9 mJ of energy to create each of the plurality of treatment regions.

### Claim 10 (depends on 5)

The treatment system of claim 5, wherein each of the plurality of treatment regions of the skin is an ablative treatment region.

### Claim 11 (depends on 10)

The treatment system of claim 10, wherein the controller is further configured to control the light source to deliver less than or equal to 17 mJ of energy to create each of the plurality of treatment regions.

### Claim 12 (depends on 1)

The treatment system of claim 1, wherein the target region is at least one of:
10 percent of the total body surface area of the skin tissue of the subject;
20 percent of the total body surface area of the skin tissue of the subject;
30 percent of the total body surface area of the skin tissue of the subject; or
32 percent of the total body surface area of the skin tissue of the subject.

### Claim 13 (depends on 12)

The treatment system of claim 12, wherein the target region does not include at least one of the genitals of the subject, or the head of the subject.

### Claim 14 (depends on 1)

The treatment system of claim 1, wherein each of the plurality of treatment regions defines a treatment surface within the target region, and the non-treatment region defines a non-treatment surface within the target region;
wherein all the treatment surfaces of the plurality of treatment regions defines a total treatment surface area of the target region; and
wherein the percentage of the treatment surface area to total surface area of the target region is at greater than or equal to 10 percent.

### Claim 15 (depends on 13)

The treatment system of claim 13, wherein the percentage of the treatment surface area to the total surface area of the treatment region is at least one of greater than or equal to 15 percent, 20 percent, 30 percent, or 32 percent.

### Claim 16 (depends on 1)

The treatment system of claim 1, wherein each of the plurality of treatment regions defines a treatment surface, and the non-treatment region defines a non-treatment surface;
wherein all the treatment surfaces of the plurality of treatment regions defines a total treatment surface area of the target region; and
wherein the percentage of the treatment surface area to the total body surface of the subject is at least 1 percent.

### Claim 17 (depends on 16)

The treatment system of claim 16, wherein the percentage of the treatment surface area to the total body surface of the subject is at least one of 2 percent, 3.6 percent, or 6.3 percent.

### Claim 18 (depends on 1)

The treatment system of claim 1, wherein the formation of the plurality of treatment regions of the target region of the skin tissue decreases an amount of fat tissue at the target region.

### Claim 19 (depends on 1)

The treatment system of claim 1, wherein the formation of the plurality of treatment regions of the target region of the skin tissue decreases a total amount of fat of the subject.

### Claim 20 (depends on 1)

The treatment system of claim 1, wherein the formation of the plurality of treatment regions of the target region of the skin tissue transforms a fat cell that is white fat cell or beige fat cell into a brown fat cell.

### Claim 21 (depends on 1)

The treatment system of claim 1, wherein the formation of the plurality of treatment regions of the target region of the skin tissue increases the amount of noradrenaline circulating through the bloodstream of the subject.

### Claim 22 (depends on 1)

The treatment system of claim 1, wherein the energy source includes a transducer.

### Claim 23 (depends on 1)

The treatment system of claim 1, wherein the energy source includes an electrical generator and one or more electrodes, the electrical generator being configured to direct an electrical signal to the one or more electrodes thereby thermally damaging the skin tissue.

### Claim 24 (depends on 1)

The treatment system of claim 1, wherein the energy source is configured to create the plurality of treatment regions without creating an incision or a puncture at the target region of the skin tissue.

### Claim 25 (depends on 1)

The treatment system of claim 1, wherein a treatment region of the plurality of treatment regions has a width of less than or equal to 1 millimeter.

### Claim 26 (depends on 1)

The treatment system of claim 1, wherein a treatment region of the plurality of treatment regions does not extend into the subcutaneous tissue of the treatment region.

### Claim 27

A treatment system comprising:
an energy source configured to thermally damage skin tissue of a subject;
a user input device configured to receive a user input;
a computing device configured to:
receive, from the user input device, the user input indicative of one or more operational parameters of the energy source;
based on the user input, control the energy source according to the one or more operational parameters to cause the energy source to thermally damage the skin tissue by creating a plurality of treatment regions within a target region of the skin tissue to decrease a total amount of fat of the subject, wherein the target region includes a non-treatment portion that is interspersed among the treatment regions.

### Claim 28

A treatment system comprising:
an energy source configured to thermally damage skin tissue of a subject;
a user input device configured to receive a user input;
a computing device configured to:
receive, from the user input device, the user input indicative of one or more operational parameters of the energy source;
based on the user input, control the energy source according to the one or more operational parameters to cause the energy source to thermally damage the skin tissue by creating a plurality of treatment regions within a target region of the skin tissue to transform one or more white fat cells into one or more beige fat cells or one or more brown fat cells, wherein the target region includes a non-treatment portion that is interspersed among the treatment regions.

### Claim 29

A method of increasing a metabolic rate, the method comprising:
directing energy, using an energy source, at a target region in skin tissue of a subject;
creating a plurality of treatment regions in the target region of the skin tissue, from the energy interacting with the skin tissue at the target region, the plurality of treatment portions being interspersed among an untreated region of the target region of the skin tissue; and
increasing the basal metabolic rate of the subject, from the creation of the plurality of treatment regions.

### Claim 30 (depends on 29)

The method of claim 29, wherein each treatment portion has a width that is less than or equal to 1 millimeter.

### Claim 31 (depends on 29)

The method of claim 29, further comprising at least one of:
decreasing an amount of fat at the target region of the skin tissue, from the creation of the plurality of treatment regions;
decreasing an amount of fat at a region of the skin tissue that is different than the target region, from the creation of the plurality of treatment regions;
decreasing a thickness of fat at the target region of the skin tissue, from the creation of the plurality of treatment regions;
decreasing a thickness of fat at the region of the skin tissue that is different than the target region, from the creation of the plurality of treatment regions; or
decreasing a total amount of fat of the subject, from the creation of the plurality of treatment regions.

### Claim 32 (depends on 29)

The method of claim 29, further comprising converting at least one white fat cell into a beige or a brown fat cell, from the creation of the plurality of treatment regions.

### Claim 33 (depends on 29)

The method of claim 29, further comprising:
increasing the concentration of at least one hormone circulating in the subject, from the creation of the plurality of treatment regions; or
increasing the concentration of at least one neurotransmitter circulating in the subject, from the creation of the plurality of treatment regions.

### Claim 34 (depends on 33)

The method of claim 33, wherein the at least one hormone or the at least one neurotransmitter is norepinephrine.

### Claim 35 (depends on 29)

The method of claim 29, wherein the plurality of treatment regions are created without puncturing or incising the skin tissue.

### Claim 36 (depends on 29)

The method of claim 29, further comprising:
moving the energy source to the target region; and
with the energy source stationary, directing energy at the target region from the energy source to create the plurality of treatment regions.

### Claim 37 (depends on 35)

The method of claim 35, further comprising:
with the energy source stationary, directing first energy at the target region from the energy source to create a first subset of the plurality of treatment regions; and
with the energy source stationary, directing second energy at the target region from the energy source to create a second subset of the plurality of treatment regions.

### Claim 38 (depends on 37)

The method of claim 37, wherein the first subset of treatment regions is a first row of treatment regions, and the second subset of the treatment regions is a second row of treatment regions.

### Claim 39 (depends on 37)

The method of claim 37, wherein the first subset of treatment regions is a first column of treatment regions, and the second subset of the treatment regions is a second column of treatment regions.

### Claim 40 (depends on 35)

The method of claim 35, wherein the target region is a first target region and further comprising:
moving the energy source to second target region that is different than the first target region; and
with the energy source stationary, directing energy at the second target region from the energy source to create another plurality of treatment regions within the second target region, the another plurality of treatment regions being interspersed with a plurality of non-treatment regions within the second target region of the skin tissue.

### Claim 41

A method of improving a weight disorder, the method comprising:
directing energy, using an energy source, at a target region in skin tissue of a subject;
creating a plurality of treatment regions in the target region of the skin tissue, from the energy interacting with the skin tissue at the target region, the plurality of treatment regions being interspersed among an untreated region of the target region of the skin tissue;
increasing the basal metabolic rate the subject, from the creation of the plurality of treatment regions;
decreasing an amount of fat of the subject, based on the increasing the basal metabolic rate of the subject; and
improving the weight disorder from the decreasing of the amount of fat of the subject.

### Claim 42 (depends on 41)

The method of claim 41, wherein each treatment region has a width that is less than or equal to 1 millimeter.

### Claim 43 (depends on 41)

The method of claim 41, further comprising at least one of:
decreasing the amount of fat at the target region of the skin tissue, from the creation of the plurality of treatment regions;
decreasing the amount of fat at a region of the skin tissue that is different than the target region, from the creation of the plurality of treatment regions;
decreasing a thickness of fat at the target region of the skin tissue, from the creation of the plurality of treatment regions;
decreasing a thickness of fat at the region of the skin tissue that is different than the target region, from the creation of the plurality of treatment regions; or
decreasing a total amount of fat of the subject, from the creation of the plurality of treatment regions.

### Claim 44 (depends on 41)

The method of claim 41, further comprising converting at least one white fat cell into a beige or a brown fat cell, from the creation of the plurality of treatment regions.

### Claim 45 (depends on 41)

The method of claim 41, further comprising:
increasing the concentration of at least one hormone circulating in the subject, from the creation of the plurality of treatment regions; or
increasing the concentration of at least one neurotransmitter circulating in the subject, from the creation of the plurality of treatment regions.

### Claim 46 (depends on 45)

The method of claim 45, wherein the at least one hormone or the at least one neurotransmitter is norepinephrine.

### Claim 47 (depends on 41)

The method of claim 41, wherein the plurality of treatment regions are created without puncturing or incising the skin tissue.

### Claim 48 (depends on 41)

The method of claim 41, further comprising improving one or more diseases caused by the weight disorder, from the creation of the plurality of treatment regions.

### Claim 49 (depends on 48)

The method of claim 48, wherein the one or more diseases include at least one of diabetes, heart disease, high blood pressure, mental illness, pain, high cholesterol, or high triglyceride levels.

### Claim 50

A method of improving one or more diseases, the method comprising:
directing energy, using an energy source, at a target region in skin tissue of a subject;
creating a plurality of treatment regions in the target region of the skin tissue, from the energy interacting with the skin tissue at the target region, the plurality of treatment regions being interspersed among a non-treatment region of the target region of the skin tissue;
decreasing an amount of fat of the subject, based on the creation of the plurality of treatment regions; and
improving the one or more diseases, based on the decreasing the amount of fat of the subject.

### Claim 51 (depends on 50)

The method of claim 50, wherein the one or more diseases include at least one of diabetes, heart disease, high blood pressure, mental illness, pain, high cholesterol, or high triglyceride levels.

### Claim 52

A treatment system comprising:
an energy source configured to thermally damage skin tissue of a subject;
a user input device configured to receive a user input;
a computing device configured to:
receive, from the user input device, the user input indicative of one or more operational parameters of the energy source;
based on the user input, control the energy source according to the one or more operational parameters to cause the energy source to thermally damage the skin tissue by creating a plurality of treatment regions within a target region of the skin tissue to increase the amount of noradrenaline circulating through the bloodstream of the subject, wherein the target region includes a non-treatment portion that is interspersed among the treatment regions.
